Concepedia

Ruiwen Zhang

RZ

Statistics

Publications

147

Citations

9.4K

H-Index

54

Active since

1991

Affiliations

University of Alabama at Birmingham(Current)

Texas Tech University Health Sciences Center

Texas Tech University

Shanghai Institutes for Biological Sciences

Chinese Academy of Sciences

Ruiwen Zhang is an author at University of Alabama at Birmingham specializing in pharmacology, oncology, and medicine.

Publications per year

1991–2025

147

Publications

147

The MDM2-p53 pathway revisited

Subhasree Nag, Satyan Kalkunte, Wang Ming-hai et al. · Journal of Biomedical Research · 2013 · 412 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy.

Zhihong Lu, Ruiwen Zhang, Robert B. Diasio · PubMed · 1993 · 374 citations

Medicine, Oncology, Pharmacology +14

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: <i>In vitro</i> and <i>In vivo</i> Activity, Chemosensitization, and Mechanisms of Action

Junmei Hou, Disong Wang, Ruiwen Zhang et al. · Clinical Cancer Research · 2008 · 321 citations · Full text

Medicine, Oncology, Pharmacology +15

Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the <i>MDM2</i> Oncogene through the PI3K/mTOR/ETS2 Pathway

Li Mao, Zhuo Zhang, Donald L. Hill et al. · Cancer Research · 2007 · 275 citations

Medicine, Oncology, Pharmacology +16

MDM2 Is a Negative Regulator of p21 , Independent of p53

Zhuo Zhang, Hui Wang, Li Mao et al. · Journal of Biological Chemistry · 2004 · 260 citations · Full text

Medicine, Cancer Biology, Oncology +11

1–5 of 147